Search -

Displaying 961 - 980 of 1862

Sort: Relevancy | Date

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

News Conference News TCT 2017

Shortened DAPT Durations Appear Safe for Patients With ACS Implanted With DES

November 01, 2017

RECAP: In the Cath Lab, a Lead-free Pad Placed on the Patient Cuts Operator Radiation Exposure

News Conference News TCT 2017

RECAP: In the Cath Lab, a Lead-free Pad Placed on the Patient Cuts Operator Radiation Exposure

November 01, 2017

Live From Denver: TCT 2017, Day Two

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

October 31, 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

October 30, 2017

Statins and Diabetes: Causal Link Reinforced in New Analysis

News Daily News

Statins and Diabetes: Causal Link Reinforced in New Analysis

Michael O'Riordan

October 25, 2017

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

October 18, 2017

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

News Daily News

What Works, What Matters? Patient-Centered Endpoints Gain Traction in CV Clinical Trials

October 13, 2017

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

News Daily News

Complications Spiked, Then Fell, After Initial Introduction of Watchman LAA Closure Device

October 12, 2017

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

News Daily News

Same-Same but Different? Noninferiority Trials Need a Revamp, NEJM Review Argues

October 06, 2017

Women Receive Less Aggressive CABG Compared With Men

News Daily News

Women Receive Less Aggressive CABG Compared With Men

Yael L. Maxwell

September 29, 2017

Better Outcomes Seen for Stroke Patients Taken Directly to Thrombectomy Hospitals, but Protocols Lacking

News Daily News

Better Outcomes Seen for Stroke Patients Taken Directly to Thrombectomy Hospitals, but Protocols Lacking

Yael L. Maxwell

September 28, 2017

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

News Daily News

Stroke, Bleeding Risks High in A-fib Patients With Contraindications to Anticoagulation

September 27, 2017

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

September 19, 2017

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

News Daily News

Three New Positive PFO Closure Studies May Turn the Tide in Cryptogenic Stroke

Yael L. Maxwell

September 18, 2017

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.